RAC1 and neoplasm: In addition to the numerous pre-clinical studies demonstrating the involvement of RAC1 in tumorigenesis, proliferation, and metastatic events, recent works have described the role of RAC1 in the development of treatment resistance,21,22,23 thus strengthening the potential therapeutic value of RAC1 blockade to suppress tumor progression and metastasis.